Study title: A Phase 2, Randomized, Double-Blind Study To Evaluate the Dosing Concentration and Application Frequency of Tacrolimus Gel in the Treatment of Mild to Moderate Psoriasis in Pediatric and Adult subjects
| Type of medicine: Centrally authorised medicines | |||||
| Therapeutic area: Skin and Connective Tissue Diseases | |||||
| Brands: Please see report | |||||
| MAH holders: Please see report | |||||
| Assessment: | |||||
| Active substance: Tacrolimus | |||||
| ATC code: D11AX14 | |||||
| Document link: | |||||
| Document date: 2011-11-10 | |||||
| Study number: Study 01-0126 | |||||
| EudraCT number: | |||||
| Scope of study: CLINICAL | |||||
| Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
| - | - | - | - | - | |